Christina Curtis1. 1. Departments of Medicine and Genetics, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California, USA.
Abstract
PURPOSE OF REVIEW: To describe recent advances in the application of advanced genomic technologies towards the identification of biomarkers of prognosis and treatment response in breast cancer. RECENT FINDINGS: Advances in high-throughput genomic profiling such as massively parallel sequencing have enabled researchers to catalogue the spectrum of somatic alterations in breast cancers. These tools also hold promise for precision medicine through accurate patient prognostication, stratification, and the dynamic monitoring of treatment response. For example, recent efforts have defined robust molecular subgroups of breast cancer and novel subtype-specific oncogenes. In addition, previously unappreciated activating mutations in human epidermal growth factor receptor 2 have been reported, suggesting new therapeutic opportunities. Genomic profiling of cell-free tumor DNA and circulating tumor cells has been used to monitor disease burden and the emergence of resistance, and such 'liquid biopsy' approaches may facilitate the early, noninvasive detection of aggressive disease. Finally, single-cell genomics is coming of age and will contribute to an understanding of breast cancer evolutionary dynamics. SUMMARY: Here, we highlight recent studies that employ high-throughput genomic technologies in an effort to elucidate breast cancer biology, discover new therapeutic targets, improve prognostication and stratification, and discuss the implications for precision cancer medicine.
PURPOSE OF REVIEW: To describe recent advances in the application of advanced genomic technologies towards the identification of biomarkers of prognosis and treatment response in breast cancer. RECENT FINDINGS: Advances in high-throughput genomic profiling such as massively parallel sequencing have enabled researchers to catalogue the spectrum of somatic alterations in breast cancers. These tools also hold promise for precision medicine through accurate patient prognostication, stratification, and the dynamic monitoring of treatment response. For example, recent efforts have defined robust molecular subgroups of breast cancer and novel subtype-specific oncogenes. In addition, previously unappreciated activating mutations in humanepidermal growth factor receptor 2 have been reported, suggesting new therapeutic opportunities. Genomic profiling of cell-free tumor DNA and circulating tumor cells has been used to monitor disease burden and the emergence of resistance, and such 'liquid biopsy' approaches may facilitate the early, noninvasive detection of aggressive disease. Finally, single-cell genomics is coming of age and will contribute to an understanding of breast cancer evolutionary dynamics. SUMMARY: Here, we highlight recent studies that employ high-throughput genomic technologies in an effort to elucidate breast cancer biology, discover new therapeutic targets, improve prognostication and stratification, and discuss the implications for precision cancer medicine.
Authors: Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol Journal: J Clin Invest Date: 2011-07 Impact factor: 14.808
Authors: Hege G Russnes; Hans Kristian Moen Vollan; Ole Christian Lingjærde; Alexander Krasnitz; Pär Lundin; Bjørn Naume; Therese Sørlie; Elin Borgen; Inga H Rye; Anita Langerød; Suet-Feung Chin; Andrew E Teschendorff; Philip J Stephens; Susanne Månér; Ellen Schlichting; Lars O Baumbusch; Rolf Kåresen; Michael P Stratton; Michael Wigler; Carlos Caldas; Anders Zetterberg; James Hicks; Anne-Lise Børresen-Dale Journal: Sci Transl Med Date: 2010-06-30 Impact factor: 17.956
Authors: Markus Wallwiener; Andreas Daniel Hartkopf; Irène Baccelli; Sabine Riethdorf; Sarah Schott; Klaus Pantel; Frederik Marmé; Christof Sohn; Andreas Trumpp; Brigitte Rack; Bahriye Aktas; Erich-Franz Solomayer; Volkmar Müller; Wolfgang Janni; Andreas Schneeweiss; Tanja Natascha Fehm Journal: Breast Cancer Res Treat Date: 2012-12-28 Impact factor: 4.872
Authors: Zsuzsanna Lichner; Andreas Scorilas; Nicole M A White; Andrew H Girgis; Lora Rotstein; Kimberly C Wiegand; Ashraf Latif; Christina Chow; David Huntsman; George M Yousef Journal: Am J Pathol Date: 2013-02-12 Impact factor: 4.307
Authors: Kimberly C Wiegand; Anna F Lee; Osama M Al-Agha; Christine Chow; Steve E Kalloger; David W Scott; Christian Steidl; Sam M Wiseman; Randy D Gascoyne; Blake Gilks; David G Huntsman Journal: J Pathol Date: 2011-05-18 Impact factor: 7.996
Authors: Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz Journal: Sci Transl Med Date: 2014-02-19 Impact factor: 17.956
Authors: Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree Journal: Nat Genet Date: 2013-05-05 Impact factor: 38.330
Authors: Scooter Willis; Yuliang Sun; Mark Abramovitz; Teng Fei; Brandon Young; Xiaoqian Lin; Min Ni; Justin Achua; Meredith M Regan; Kathryn P Gray; Robert Gray; Victoria Wang; Bradley Long; Roswitha Kammler; Joseph A Sparano; Casey Williams; Lori J Goldstein; Roberto Salgado; Sherene Loi; Giancarlo Pruneri; Giuseppe Viale; Myles Brown; Brian Leyland-Jones Journal: JCO Precis Oncol Date: 2017-10-13
Authors: Zhi Hu; Jian-Hua Mao; Christina Curtis; Ge Huang; Shenda Gu; Laura Heiser; Marc E Lenburg; James E Korkola; Nora Bayani; Shamith Samarajiwa; Jose A Seoane; Mark A Dane; Amanda Esch; Heidi S Feiler; Nicholas J Wang; Mary Ann Hardwicke; Sylvie Laquerre; Jeff Jackson; Kenneth W Wood; Barbara Weber; Paul T Spellman; Samuel Aparicio; Richard Wooster; Carlos Caldas; Joe W Gray Journal: Breast Cancer Res Date: 2016-07-01 Impact factor: 6.466
Authors: Ana Vila; Miguel Abal; Laura Muinelo-Romay; Carlos Rodriguez-Abreu; José Rivas; Rafael López-López; Clotilde Costa Journal: PLoS One Date: 2016-10-06 Impact factor: 3.240